Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ RecruitingNot Applicable A Randomized Open label Single Dose Two Treatment Three Period Three Sequence Partial Replicate Crossover Multicentre Bioequivalence Study of Capecitabine Biopharm 500 mg film coated Tablets (Manufactured by Profam Algeria for Biopharm SPA Algeria) with Xeloda® 500 mg Film Coated Tablets Capecitabine (Manufacturer Excella GmbH and Co KG Germany and Marketing Authorisation Holder CHEPLAPHARM Arzneimittel GmbH Germany in Adult Cancer Patients Under Fed Conditions - NIL
100 Clinical Results associated with Biopharm SpA
0 Patents (Medical) associated with Biopharm SpA
100 Deals associated with Biopharm SpA
100 Translational Medicine associated with Biopharm SpA